Federal contractor profile

DNA TWOPOINTO INC.

UEI G9S3SC8T5DM1CAGE 3ENW7Company website ↗

Active

Small Business

Overview

Legal name: DNA TWOPOINTO INC.
Also known as: DNA TWOPOINTO INC
Registered location: NEWARK, CA, USA
Website: Company website ↗
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity: Jul 20, 2026

Read company summary

DNA TWOPOINTO INC. is associated with UEI G9S3SC8T5DM1 and CAGE 3ENW7 in public federal records. AcornBids currently links 1 prime award totaling $300.0K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Biological Product (except Diagnostic) Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists NEWARK, CA, USA.

At a glance

Lifetime prime obligations$300.0K

Prime awards1

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: DNA TWOPOINTO INC.
Doing business as: DNA TWOPOINTO INC
UEI: G9S3SC8T5DM1
CAGE: 3ENW7
Registered address: 37950 CENTRAL CT, NEWARK, CA, 94560, USA
Registration status: Active
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation: Jul 16, 2026
Initial registration: Apr 4, 2003
Entity start: Feb 14, 2003
SAM updated: Jul 16, 2026
Registration expires: Jul 14, 2027
Fiscal year end: Dec 31
Place of incorporation: CA, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
75N93023P00594YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY	Department of Health and Human Services	$300.0K	May 14, 2023	May 13, 2028

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY

Department of Health and Human Services$300.0K obligationsEnds May 13, 202870% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Jul 16, 2026
Source loaded	Sep 26, 2026
Initial registration	Apr 4, 2003
Entity start	Feb 14, 2003

Registration classifications: Small Business. These are separate from the reported certificates above.

Industry	Reported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)	Not reported

Contact	Role	Published contact methods	Evidence	Source date
CLAES GUSTAFSSON	Government business	Contact method not published	SAM registration	Not available
JEREMY MINSHULL	Alternate government business	Contact method not published	SAM registration	Not available
FRANCES STEINGRIMSSON	Electronic business	Contact method not published	SAM registration	Not available
JEREMY MINSHULL	Alternate electronic business	Contact method not published	SAM registration	Not available

Registered industries

541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source